HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): William L. Holman Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Digerness, S. B. Articles by Holman, W. L. Search for Related Content PubMed PubMed Citation Articles by Digerness, S. B. Articles by Holman, W. L. Related Collections Cardiac - pharmacology Myocardial protection

J Thorac Cardiovasc Surg 2003;125:863-871
© 2003 The American Association for Thoracic Surgery

Cardiopulmonary Support and Physiology

Modulation of mitochondrial adenosine triphosphate-sensitive potassium channels and sodium-hydrogen exchange provide additive protection from severe ischemia-reperfusion injury

From the Departments of Surgery,^a Pathology,^b and Biostatistics,^c University of Alabama at Birmingham, Birmingham, Ala.

Received for publication Feb 14, 2002. Revisions requested April 30, 2002; revisions received May 24, 2002. Accepted for publication July 15, 2002. Address for reprints: William L. Holman, MD, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL 35294-0007 (E-mail: wholman{at}its.uab.edu).

Background: Preconditioning and inhibition of sodium-proton exchange attenuate myocardial ischemia-reperfusion injury by means of independent mechanisms that might act additively when used together. The hypothesis of this study is that treatment with a sodium-proton exchange inhibitor and a mitochondrial adenosine triphosphate-sensitive potassium channel opener produces superior functional recovery and a greater decrease in left ventricular infarct size compared with treatment with either drug alone in a model of severe global ischemia.
Methods: Isolated crystalloid-perfused rat hearts (n = 8 hearts per group) were administered vehicle (control, 0.04% dimethyl sulfoxide), diazoxide (100 µmol/L in 0.04% dimethyl sulfoxide), cariporide (10 µmol /L in 0.04% dimethyl sulfoxide), or diazoxide and cariporide before 40 minutes of ischemia at 35.5°C to 36.5°C and 30 minutes of reperfusion.
Results: The combination group had superior postischemic systolic function compared with that seen in the cariporide, diazoxide, and control groups (recovery of developed pressure: 91% ± 7% vs 26% ± 5%, 35% ± 6%, and 16% ± 3%, respectively; P < .05). Postischemic diastolic function in the combination group was superior compared with that seen in the other groups (change_pre-post diastolic pressure of 67 ± 4 mm Hg with control, 49 ± 11 mm Hg with diazoxide, 59 ± 10 mm Hg with cariporide, and 3 ± 3 mm Hg with diazoxide and cariporide combination; P < .05). The left ventricular infarct area was less in the combination group compared with that in the cariporide, diazoxide, and control groups (6% ± 2% vs 35% ± 7%, 25% ± 3%, and 37% ± 9%, respectively; P < .05).
Conclusions: Combining a selective mitochondrial adenosine triphosphate-sensitive potassium channel opener with a selective reversible inhibitor of sarcolemmal sodium-proton exchange improves recovery of contractile function from severe global ischemia in the isolated buffer-perfused rat heart. The putative mechanism for this benefit is superior protection of mitochondrial function.